23.06
전일 마감가:
$24.00
열려 있는:
$23.35
하루 거래량:
9,378
Relative Volume:
4.08
시가총액:
$N/A
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
-0.17%
1개월 성능:
+3.17%
6개월 성능:
-3.92%
1년 성능:
-11.31%
Lifemd Inc Stock (LFMDP) Company Profile
명칭
Lifemd Inc
전화
866 351 5907
주소
236 Fifth Avenue, Suite 400, New York
Compare LFMDP vs HITI, PETS, POM, HKPD, SCNX
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
LFMDP
Lifemd Inc
|
23.06 | 0 | 0 | 0 | 0 | 0.00 |
|
HITI
High Tide Inc
|
2.31 | 203.04M | 452.61M | -35.30M | 13.25M | -0.3863 |
|
PETS
Petmed Express Inc
|
2.29 | 49.01M | 182.67M | -64.87M | -22.92M | -3.1193 |
|
POM
Pomdoctor Ltd Adr
|
0.2447 | 29.17M | 0 | 0 | 0 | 0.00 |
|
HKPD
Cellyan Biotechnology Co Ltd
|
0.569 | 13.37M | 0 | 0 | 0 | 0.00 |
|
SCNX
Scienture Holdings Inc
|
0.2963 | 12.04M | 653.40K | -20.19M | -11.11M | -1.8091 |
Lifemd Inc 주식(LFMDP)의 최신 뉴스
LifeMD Earnings Call Highlights Aggressive Growth Push - tipranks.com
LifeMD, Inc. (LFMDP) Stock Price, News, Quote & History - Yahoo! Finance Canada
LFMDP SEC FilingsLifemd, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
200,000 LifeMD (LFMD) RSUs awarded to marketing head - Stock Titan
[Form 3] LifeMD, Inc. Initial Statement of Beneficial Ownership - Stock Titan
LifeMD (LFMD) CFO Atul Kavthekar listed as reporting person in Form 3 - Stock Titan
LifeMD launches Wegovy subscription program with Novo Nordisk By Investing.com - za.investing.com
LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program - Bitget
Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Benzinga
NVO: Novo Nordisk's Wegovy Subscription Program Launches with Li - GuruFocus
LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program - GlobeNewswire
Up to $1,200 off Wegovy: LifeMD launches Novo telehealth plan - Stock Titan
Novo to sell Wegovy subscriptions on Hims, LifeMD, and others - Seeking Alpha
Earnings Miss: Why is LifeMD Inc stock going up2026 Risk Factors & Breakout Confirmation Trade Signals - baoquankhu1.vn
LifeMD Offers Novo Nordisk’s Ozempic For $499 A Month To Eligible Patients - MSN
LifeMD: Comparing The High Yield Preferred Stock To An Options Income Strategy (LFMD) - Seeking Alpha
LifeMD, Inc. 8.875% CUM PFD A declares $0.5547 dividend - MSN
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
How Lifemd Inc. 8.875% Series A Cumulative Perpetual Preferred Stock (LFMDP) Affects Rotational Strategy Timing - Stock Traders Daily
LFMD Technical Analysis | Trend, Signals & Chart Patterns | LIFEMD INC (NASDAQ:LFMD) - ChartMill
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - tradingview.com
[144] LifeMD, Inc. SEC Filing - Stock Titan
LifeMD appoints Atul Kavthekar as CFO - MSN
If You Invested $1,000 in Lifemd, Inc. (LFMDP) - Stock Titan
If You Invested $1,000 in Lifemd Inc (LFMD) - Stock Titan
LifeMD appoints new CFO; shares up - MSN
How The LifeMD (LFMD) Story Is Shifting On GLP‑1 Growth And Higher 2026 Targets - Yahoo Finance
LifeMD Appoints Atul Kavthekar as CFO and Expands Leadership Team to Drive AI-First Healthcare Growth 1 - Minichart
LifeMD Announces CFO Transition and Expanded Leadership Team - TipRanks
LifeMD (NASDAQ: LFMD) installs new CFO and expands leadership team - Stock Titan
LifeMD (LFMD) to Participate in B. Riley's Virtual Meeting on Ma - gurufocus.com
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG) - The Globe and Mail
LifeMD, Inc. (NASDAQ:LFMD) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
LifeMD names Atul Kavthekar as CFO, announces leadership changes By Investing.com - Investing.com India
LifeMD, Inc. Announces Chief Financial Officer Changes - marketscreener.com
Lifemd, Inc. Announces Executive Appointments - marketscreener.com
LifeMD shares are trading higher after the co... - Benzinga
LifeMD Inc announced appointment of Atul Kavthekar as chief financial officer - marketscreener.com
LifeMD names Atul Kavthekar as CFO, announces leadership changes - Investing.com
LifeMD (NASDAQ:LFMD) Raised to Outperform at Mizuho - MarketBeat
LifeMD Inc Announced Appointment Of Atul Kavthekar As Chief Financial Officer - TradingView
LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team - GlobeNewswire
This Upstart Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday - Benzinga
Mizuho Upgrades LifeMD (LFMD) with Raised Price Target to $8.00 - GuruFocus
Mizuho upgrades LifeMD stock rating on weight-loss outlook By Investing.com - Investing.com Australia
Mizuho upgrades LifeMD stock rating on weight-loss outlook - Investing.com Nigeria
LifeMD outlines $250M+ annualized revenue run rate target by Q4 2026 amid record GLP-1 demand and expanded partnerships - MSN
LifeMD (LFMD) Is Up 32.7% After Returning To Profitability And Expanding GLP‑1 Telehealth Offerings - simplywall.st
Lifemd Inc (LFMDP) 재무 분석
Lifemd Inc (LFMDP)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):